Search for: "In re: Abbott Laboratories"
Results 121 - 140
of 236
Sorted by Relevance
|
Sort by Date
16 Apr 2013, 6:51 am
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004)), and the plaintiffs played the same non-severability card. [read post]
6 Mar 2013, 4:30 am
Abbott Laboratories, 2013 U.S. [read post]
29 Mar 2024, 2:36 am
Menninger was hired by PPD in 2015 to lead its laboratory services. [read post]
29 Mar 2024, 2:36 am
Menninger was hired by PPD in 2015 to lead its laboratory services. [read post]
9 Aug 2012, 5:00 am
Sanchez & Abbott Labs. [read post]
25 May 2009, 5:20 pm
Todd Dickinson’s comments at Bio Conference (IAM) The Charles Rivers Ventures connection – CRV stakes in RPX Corp, Thinkfire and Intellectual Ventures (IAM) Obama Administration tackling patent backlog (IP Watchdog) Patent examiners told to issue patents (IP Watchdog) More funding needed for patent granting authority (IP Watchdog) Short note on patentability of product-by-process claims – Newman J’s opinion in 1985 case In re Thorpe: Abbott v… [read post]
7 Jan 2014, 5:26 pm
Abbott Laboratories spent $80 million advertising AndroGel last year. [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) – Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) – US: Watson and Barr settle patent litigation (SmartBrief)… [read post]
8 Jan 2007, 7:07 am
Abbott Laboratories (06-475), involving a dispute among lower courts on when a missing filing deadline in federal courts can be excused. ** EchoStar Communications v. [read post]
14 Dec 2013, 1:37 pm
Abbott Laboratories spent $80 million advertising AndroGel last year. [read post]
18 Feb 2010, 6:23 pm
Re-development of the NoMa neighborhood has resulted in the warehouse becoming the new U.S. [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) – Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) – US: Watson and Barr settle patent litigation… [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) - Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) - US: Watson and Barr settle patent litigation (SmartBrief) Plavix… [read post]
7 Jul 2008, 7:06 pm
The risk of giving statins at a lower age is less than the benefit you're going to get out of it. [read post]
22 Jul 2007, 10:31 am
Another federal judge in Ohio entered a wholesale order dismissing litigation against the diet drug Meridia, based on the argument of its manufacturer, Abbott Laboratories, that the drug's warning label protected it from liability.More about the Judicial Panel on Multi-District Litigation. [read post]
29 Mar 2023, 9:02 pm
As illustration, for the incidence of another pathogen that is of low frequency but high severity, Listeria monocytogenes, the CDC estimates that there are 0.31 laboratory-diagnosed, domestically acquired infections per 100,000 population. [read post]
29 Mar 2012, 9:55 am
Abbott Laboratories, 747 N.Y.S.2d 863, 866 (N.Y. [read post]
13 Jul 2011, 3:04 am
(BIOtechNOW) US: PTO agrees to reexamine broad codon-optimization patents (Holman’s Biotech IP Blog) US: Inherently incomprehensible: Does the CAFC’s view of inherency in In Re Kao spell the end of second medical use patents in the USA? [read post]
27 May 2010, 3:20 am
(Spicy IP) Trilipix (Fenofibrate) – US: Patent infringement complaint following Paragraph IV challenge: Abbott Laboratories et al. v. [read post]
15 Apr 2020, 6:38 am
“You feel like you’re suffocating,” recalled Boroff, a real estate agent in Maineville, Ohio. [read post]
